Onkolytische Virotherapie, Virus-Vektoren
Erstellt am 18 May 2017 13:42 - Zuletzt geändert: 08 May 2018 21:35
- Bei der EMA zugelassene Präparate mit Virus-Vektoren
- Orphan Designations der EMA für Virus-Vektoren
- Review: Combining Oncolytic Virotherapy with p53 Tumor Suppressor Gene Therapy (2017)
- Review: Combining Oncolytic Virotherapy with p53 Tumor Suppressor Gene Therapy (2017; PMID)
- Review: Virotherapy: cancer gene therapy at last? (2016; PMID)
- Cancer.gov: Ad5CMV-p53 gene - Advexin
- Nature News vom 08.05.2018: Cancer-killing viruses show promise — and draw billion-dollar Investment
- Ribas A, Dummer R, Puzanov I, et al. Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy. Cell. 2017 Sep 7;170(6):1109-1119.e10. doi: 10.1016/j.cell.2017.08.027.